ATC Group: H02AB09 Hydrocortisone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of H02AB09 in the ATC hierarchy

Level Code Title
1 H Systemic hormonal preparations, excl. Sex hormones and insulins
2 H02 Corticosteroids for systemic use
3 H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
4 H02AB Glucocorticoids
5 H02AB09 Hydrocortisone

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 30 mg
PAREN - Parenteral 30 mg

Active ingredients in H02AB09

Active Ingredient Description
Hydrocortisone

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.

Related product monographs

Title Information Source Document Type  
ALKINDI Granule in capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CORTEF Tablet FDA, National Drug Code (US) MPI, US: SPL/Old
HYDROCORTISONE 1% w/w Ointment Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HYDROCORTISONE Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HYDROCORTISONE Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HYDROCORTISONE Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HYDROCORTONE Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
PLENADREN Modified-release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
Solu-Cortef Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Ecuador (EC)

France (FR)

Hong Kong (HK)

Israel (IL)

Italy (IT)

Japan (JP)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.